Characterization of LDL binding in TR 715-19 cells. A high capacity, stable line for evaluating the binding of LDL to the human LDL receptor.
Hara
H
H
Clinical Diabetes and Nutrition Section, National Institutes of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ.
Howard
B V
BV
D000818:Animals; D002452:Cell Count; D002460:Cell Line; D002499:Centrifugation, Density Gradient; D008078:Cholesterol, LDL / Q000378:metabolism; D006224:Cricetinae; D003412:Cricetulus; D005347:Fibroblasts / Q000166:cytology; D006801:Humans; D008077:Lipoproteins, LDL / Q000378:metabolism*; D010743:Phospholipids / Q000378:metabolism; D011869:Radioligand Assay; D011973:Receptors, LDL / Q000378:metabolism*; D014280:Triglycerides / Q000378:metabolism
D008078:Cholesterol, LDL; D008077:Lipoproteins, LDL; D010743:Phospholipids; D011973:Receptors, LDL; D014280:Triglycerides